ArticleAntibiotics (Basel, Switzerland)2021

Cnicin as an Anti-SARS-CoV-2: An Integrated In Silico and In Vitro Approach for the Rapid Identification of Potential COVID-19 Therapeutics.

Hani A Alhadrami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.